生工有限公司

免付費服務專線:080-007-2222

產品櫥窗

  • MK-2206, dihydrochloride
  • 產品型號:101-1032350-13-2

    商品規格:

    商品售價

Highly selective inhibitor of Akt1/2/3

C25H23Cl2N5O
MW: 480.39

Three related forms of the kinase Akt (1, 2, 3, also known as protein kinase B isoforms PKBα, β, γ) modulate cell proliferation, metabolism, and survival as well as angiogenesis. MK-2206 is an orally active, allosteric Akt inhibitor that is equally potent toward purified human recombinant Akt1 and Akt2 (IC50s = 5 and 12 nM, respectively) and approximately 5-fold less potent against human Akt3 (IC50 = 65 nM). In combination with other anticancer agents including topoisomerase inhibitors, antimetabolites, antimicrotubule agents, DNA cross-linkers or growth factor inhibitors, MK-2206 has been shown to synergistically inhibit cell proliferation of human cancer cell lines. At 5 μM, MK-2206 significantly enhances apoptosis in hematopoietic cells treated with chemotherapeutics.

Solubility: 14 mg/mL (29.14 mM) in DMSO

Store at -20oC